A drug that's been tested against the coronaviruses that cause MERS and SARS and shown to have valuable antiviral properties appears to be potent against the COVID-19 virus as well.
Copyright 2020 NPR
Joe Palca is a science correspondent for NPR. Since joining NPR in 1992, Palca has covered a range of science topics — everything from biomedical research to astronomy. He is currently focused on the eponymous series, "Joe's Big Idea." Stories in the series explore the minds and motivations of scientists and inventors. Palca is also the founder of NPR Scicommers – A science communication collective.